BIOMAT Database Logo BIOMAT Database Logo

A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients. 1996

R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
University of Nebraska Medical Center, Department of Surgery, Omaha, 68198-3280, USA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007654 Ketoconazole Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. Nizoral,R-41400,R41,400,R41400,R 41400
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011654 Pulmonary Edema Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening. Wet Lung,Edema, Pulmonary,Edemas, Pulmonary,Pulmonary Edemas,Lung, Wet,Lungs, Wet,Wet Lungs
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy.
January 1992, Archives of surgery (Chicago, Ill. : 1960),
R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
Induction therapy with OKT3 in pediatric liver-transplant recipients.
December 1994, Transplantation science,
R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
Low-dose Thymoglobulin vs Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: A Prospective Randomized Trial.
April 2021, Transplantation proceedings,
R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.
April 1999, Transplantation,
R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation.
February 1991, Transplantation proceedings,
R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: a single-center report.
April 2005, Transplantation,
R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy.
October 1997, Transplantation,
R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
A comparison of daclizumab to ATGAM induction in simultaneous pancreas-kidney transplant recipients on triple maintenance immunosuppression.
August 2000, Clinical transplantation,
R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
MALG vs OKT3 following renal transplantation: a randomized prospective trial.
February 1991, Transplantation proceedings,
R J Stratta, and R J Taylor, and L G Weide, and R Sindhi, and D Sudan, and P Castaldo, and K A Cushing, and K Frisbie, and S J Radio
Leukocyte response to thymoglobulin or atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients.
May 1999, Transplantation proceedings,
Copied contents to your clipboard!